21. JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis. (1st February 2018) Authors: Bissonnette, R. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Persistence of interleukin (IL)‐17A+ T lymphocytes and IL‐17A expression in treatment‐resistant psoriatic plaques despite ustekinumab therapy. (1st July 2017) Authors: Jack, C.; Mashiko, S.; Arbour, N.; Bissonnette, R.; Sarfati, M. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. ASN002 证明有疗效并可改善AD 炎症. (1st October 2019) Authors: Bissonnette, R.; Maari, C.; Forman, S.; Bhatia, N.; Lee, M.; Fowler, J.; Tyring, S.; Pariser, D.; Sofen, H.; Dhawan, S.; Zook, M.; Zammit, D.J.; Usansky, H.; Denis, L.; Rao, N.; Song, T.; Pavel, A.B.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis. (1st October 2018) Authors: Ryan, C.; Menter, A.; Guenther, L.; Blauvelt, A.; Bissonnette, R.; Meeuwis, K.; Sullivan, J.; Cather, J.C.; Yosipovitch, G.; Gottlieb, A.B.; Merola, J.F.; Callis Duffin, K.; Fretzin, S.; Osuntokun, O.O.; Burge, R.; Naegeli, A.N.; Yang, F.E.; Lin, C.‐Y.; Todd, K.; Potts Bleakman, A. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. 伊赛珠单抗在中度至重度生殖器银屑病中的疗效和安全性. (1st October 2018) Authors: Ryan, C.; Menter, A.; Guenther, L.; Blauvelt, A.; Bissonnette, R.; Meeuwis, K.; Sullivan, J.; Cather, J.C.; Yosipovitch, G.; Gottlieb, A.B.; Merola, J.F.; Callis Duffin, K.; Fretzin, S.; Osuntokun, O.O.; Burge, R.; Naegeli, A.N.; Yang, F.E.; Lin, C.‐Y.; Todd, K.; Potts Bleakman, A. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: e189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Ixekizumab efficacy and safety in moderate‐to‐severe genital psoriasis. (1st October 2018) Authors: Ryan, C.; Menter, A.; Guenther, L.; Blauvelt, A.; Bissonnette, R.; Meeuwis, K.; Sullivan, J.; Cather, J.C.; Yosipovitch, G.; Gottlieb, A.B.; Merola, J.F.; Callis Duffin, K.; Fretzin, S.; Osuntokun, O.O.; Burge, R.; Naegeli, A.N.; Yang, F.E.; Lin, C.‐Y.; Todd, K.; Potts Bleakman, A. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: e177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement. (12th March 2019) Authors: Leshem, Y.A.; Bissonnette, R.; Paul, C.; Silverberg, J.I.; Irvine, A.D.; Paller, A.S.; Cork, M.J.; Guttman‐Yassky, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 5(2019) Page Start: 807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE). (16th May 2015) Authors: Thaçi, D.; Humeniuk, J.; Frambach, Y.; Bissonnette, R.; Goodman, J.J.; Shevade, S.; Gong, Y.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis. (14th February 2018) Authors: Bissonnette, R. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials. (6th October 2020) Authors: Bieber, T.; Thyssen, J.P.; Reich, K.; Simpson, E.L.; Katoh, N.; Torrelo, A.; De Bruin‐Weller, M.; Thaci, D.; Bissonnette, R.; Gooderham, M.; Weisman, J.; Nunes, F.; Brinker, D.; Issa, M.; Holzwarth, K.; Gamalo, M.; Riedl, E.; Janes, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗